Aviad Friedman Oramed Pharmaceuticals Inc. (ORMP) insider trading activity
Aviad Friedman is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 0 shares of ORMP, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2022, when has been sold 6,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
AF
Aviad Friedman
Director
Tel Aviv,, L3